Low-intensity shockwave therapy improves erectile function in trials, but guidelines continue to classify it as ...

It’s more common than many people think,” says Arvind Kanda, Head of India & Access Markets at Viatris, as the global healthcare company pushes to break the silence around erectile dysfunction (ED) in ...

As a board-certified urologist who specializes in male sexual dysfunction and men’s health, I often find that people can be pretty dismissive of treatment for erectile dysfuncti ...

GLP-1 weight loss drugs may increase erectile dysfunction risk in men with Type 2 diabetes, but experts say evidence is ...

Weight Loss And Metabolic Shifts: Rapid weight loss and metabolic changes may alter hormone levels, which can influence ...

Accra, April 19, GNA – Viatris, a global healthcare company, has taken its EmpowerED for Life campaign to the streets of Accra to promote open discussion on erectile dysfunction (ED). The exercise, ...

GLP-1 receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 ...

A 2026 observational study suggests GLP-1 receptor agonists may be associated with a modest increase in erectile dysfunction ...

Find out more about the association between GLP-1 use in patients with Type 2 diabetes and erectile dysfunction.

In an effort to break long-standing taboos surrounding men’s sexual health, global healthcare company Viatris has taken its ...

Many men with ED - erectile dysfunction - think it's an isolated problem, and don't tell their doctors. However, they should ...